Transcatheter Mitral Valve Replacement for Rheumatic Mitral Stenosis
Author Information
Author(s): Jin Ping, Guo Hong, Mao Yu, Zhai Mengen, Liu Yang, Yang Jian
Primary Institution: Xijing Hospital, Air Force Medical University, Xi’an, China
Hypothesis
We sought to evaluate the early experience of patients with RMS undergoing transcatheter mitral valve replacement (TMVR).
Conclusion
Our early experience with TMVR in RMS patients suggests that it is a safe and feasible procedure.
Supporting Evidence
- TMVR was successful in all patients.
- 60% of patients had no paravalvular leakage postoperatively.
- No deaths occurred at the 30-day follow-up.
- All patients had an improvement of ≥1 on the New York Heart Association functional rating.
Takeaway
Doctors used a new method to help patients with a heart valve problem, and it worked well for everyone.
Methodology
This was a retrospective study involving 5 RMS patients who underwent TMVR, with evaluations before and after the procedure.
Potential Biases
Procedures were completed by interventionists, and there is a lack of standardized procedures.
Limitations
This is a single-center study with a small sample size, and the follow-up period is relatively short.
Participant Demographics
Median age was 61 years, with 60% male participants.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website